482 related articles for article (PubMed ID: 22240481)
1. Diverse functional properties of Wilson disease ATP7B variants.
Huster D; Kühne A; Bhattacharjee A; Raines L; Jantsch V; Noe J; Schirrmeister W; Sommerer I; Sabri O; Berr F; Mössner J; Stieger B; Caca K; Lutsenko S
Gastroenterology; 2012 Apr; 142(4):947-956.e5. PubMed ID: 22240481
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
Forbes JR; Cox DW
Am J Hum Genet; 1998 Dec; 63(6):1663-74. PubMed ID: 9837819
[TBL] [Abstract][Full Text] [Related]
4. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
5. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B.
Wan L; Tsai CH; Hsu CM; Huang CC; Yang CC; Liao CC; Wu CC; Hsu YA; Lee CC; Liu SC; Lin WD; Tsai FJ
Hepatology; 2010 Nov; 52(5):1662-70. PubMed ID: 20931554
[TBL] [Abstract][Full Text] [Related]
7. Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.
Dmitriev OY; Bhattacharjee A; Nokhrin S; Uhlemann EM; Lutsenko S
J Biol Chem; 2011 May; 286(18):16355-62. PubMed ID: 21398519
[TBL] [Abstract][Full Text] [Related]
8. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
[TBL] [Abstract][Full Text] [Related]
9. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.
Hasan NM; Gupta A; Polishchuk E; Yu CH; Polishchuk R; Dmitriev OY; Lutsenko S
J Biol Chem; 2012 Oct; 287(43):36041-50. PubMed ID: 22898812
[TBL] [Abstract][Full Text] [Related]
10. Wilson disease.
Harada M
Med Electron Microsc; 2002 Jun; 35(2):61-6. PubMed ID: 12181646
[TBL] [Abstract][Full Text] [Related]
11. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.
Forbes JR; Cox DW
Hum Mol Genet; 2000 Aug; 9(13):1927-35. PubMed ID: 10942420
[TBL] [Abstract][Full Text] [Related]
12. Critical roles for the COOH terminus of the Cu-ATPase ATP7B in protein stability, trans-Golgi network retention, copper sensing, and retrograde trafficking.
Braiterman L; Nyasae L; Leves F; Hubbard AL
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G69-81. PubMed ID: 21454443
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional insights of Wilson disease copper-transporting ATPase.
Fatemi N; Sarkar B
J Bioenerg Biomembr; 2002 Oct; 34(5):339-49. PubMed ID: 12539961
[TBL] [Abstract][Full Text] [Related]
14. Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B.
Braiterman L; Nyasae L; Guo Y; Bustos R; Lutsenko S; Hubbard A
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G433-44. PubMed ID: 19033537
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
[TBL] [Abstract][Full Text] [Related]
16. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
17. Copper does not alter the intracellular distribution of ATP7B, a copper-transporting ATPase.
Harada M; Sakisaka S; Kawaguchi T; Kimura R; Taniguchi E; Koga H; Hanada S; Baba S; Furuta K; Kumashiro R; Sugiyama T; Sata M
Biochem Biophys Res Commun; 2000 Sep; 275(3):871-6. PubMed ID: 10973814
[TBL] [Abstract][Full Text] [Related]
18. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders.
Fieten H; Gill Y; Martin AJ; Concilli M; Dirksen K; van Steenbeek FG; Spee B; van den Ingh TS; Martens EC; Festa P; Chesi G; van de Sluis B; Houwen RH; Watson AL; Aulchenko YS; Hodgkinson VL; Zhu S; Petris MJ; Polishchuk RS; Leegwater PA; Rothuizen J
Dis Model Mech; 2016 Jan; 9(1):25-38. PubMed ID: 26747866
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
[TBL] [Abstract][Full Text] [Related]
20. Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2011 Mar; 286(12):10073-83. PubMed ID: 21242307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
